Back to search

Article

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve out- come in severe cases

2020-05-15

Abstract excerpt

Current management efforts of COVID-19 include: early diagnosis, use of antivirals, and immune modulation. After the initial viral phase of the illness, identification of the patients developing cytokine storm syndrome is critical.1, 2 Treatment of hyper- inflammation in these patients using existing, approved therapies with proven safety profiles could address the immediate need to reduce the rising mortality.3 T...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f3890f5e-49b6-5e2d-94db-e9012f814035
DOI
10.21203/rs.3.rs-29392/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve out- come in severe casesDOI 10.21203/rs.3.rs-29392/v1
COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe casesSemantic proximity
Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolutionSemantic proximity
Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity
Inflammatory phenotyping predicts clinical outcome in COVID-19.Semantic proximity
COVID-19–Associated Macrophage Activation Syndrome: Clinical Characteristics, Treatment Patterns, and Outcomes from a Hospitalized CohortSemantic proximity
Transcriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine ApproachSemantic proximity
An In-Silico Analysis of Drugs Potentially Modulating the Cytokine Storm Triggered by SARS-CoV-2 Infection<strong> </strong>Semantic proximity
<i>In vitro</i> Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19Semantic proximity
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated reviewSemantic proximity
A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir Vs Currently Used Therapy in Severe COVID-19 Adults. (COMVIVIR, clinicaltrials.gov NCT04475991)Semantic proximity
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and may be modified by dexamethasoneSemantic proximity
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasoneSemantic proximity
Select a neighboring publication to make it the new centre.